Cambridge Healthtech Institute’s 2nd Annual

Immuno-Oncology Investing & Partnering Forum

Partnering, Funding & Investment to Advance Immuno-Oncology Therapeutics

August 8, 2019



The 2nd Annual Immuno-Oncology Investing & Partnering Forum brings together early and late-stage investors with fund raising CEOs and research entrepreneurs to encourage partnering and investment, and to ultimately accelerate immune-oncology therapies to market. This Forum will provide ample opportunity for both investors and CEOs to interact through pre-scheduled 1-1 meetings, as well as interactive panels presented by pharma business development and the VC/investment community.

PANEL DISCUSSION: Partnering and Licensing in Immuno-Oncology
Big pharma, biotech and medtech need to act to capitalize new innovations that provide solutions to the global demands in healthcare. This insider panel will discuss their areas of interest for in-licensing novel therapeutics, devices and diagnostics and what they look for in a partner or investment.

Panelists: Michael Woo, MBA, Head, Search & Evaluation, Immuno-Oncology, Business Development & Licensing, Novartis Institutes for BioMedical Research, Inc.

Kathryn McCabe, PhD, Senior Director, Business Development, Emerging Technology and Innovation, Eli Lilly and Company

Scott M. DeWire, PhD, Global Head, Business Development and Licensing, Cancer Immunology, Boehringer Ingelheim Pharmaceuticals, Inc.

PANEL DISCUSSION: Corporate Venture Capital for Oncology and Immuno-Oncology
In this panel discussion, we will hear from venture capitalists representing arms of pharma companies. What are the benefits of working with a corporate venture capital entity vs private or angel? What are pharma and biotech venture capitalists looking for in a startup company?

Panelists: Alexis Ji, PhD, Partner, Illumina Ventures

John Gustofson, Managing Director, AbbVie Ventures

Novel Therapeutics and Diagnostics for Cancer Immunotherapy
In this session, we will hear from companies on the cutting edge. Novel drugs are being developed and commercialized, and new pathways for cancer diagnostics are being discovered and targeted. Innovative technology is yielding benefits in development of diagnostics and treatments. Hear from leading companies on their approaches.

Session Speaker:  Stephen J Russell, MD, PhD, CEO, Vyriad Inc.

Start-Up Showcase
The Immuno-Oncology Investing & Partnering Forum’s 2nd Annual Start-Up Showcase offers the stage to young immuno-oncology companies to pitch their drug, device, diagnostic, or software to an audience of investors, CEOs, and executives in the field.

We are now accepting showcase proposals! View more information and submit your proposal here


For more details on the conference, please contact:
Kaitlyn Barago
Associate Conference Producer
Cambridge Healthtech Institute
Phone: (+1) 781-972-6282
Email: kbarago@healthtech.com

For partnering and sponsorship information, please contact:
Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-247-6286
Email: reymael@healthtech.com

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag



Connect With Us

MEETING SUGGESTIONS

For meeting questions or suggestions, please contact:

Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
juliab@healthtech.com

PARTNERING & SPONSORSHIP

For partnering and sponsorship info, please contact:

Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
+1 781.247.6286
reymael@healthtech.com

MEDIA & ASSOCIATION

For media and association partnerships, please contact:

Pete DeOlympio
Sr. Marketing Manager
Cambridge Healthtech Institute
+1 781.972.5415
peted@healthtech.com